Medexus Pharmaceuticals (OTCMKTS:MEDXF) Trading Down 1.3% – Here’s What Happened

Shares of Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF) traded down 1.3% during mid-day trading on Monday . The company traded as low as $3.00 and last traded at $3.00. 16,535 shares were traded during trading, a decline of 60% from the average session volume of 41,094 shares. The stock had previously closed at $3.04.

Medexus Pharmaceuticals Trading Down 6.7 %

The firm has a 50-day simple moving average of $2.16 and a 200-day simple moving average of $1.92.

Medexus Pharmaceuticals Company Profile

Medexus Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada and the United States. The company focuses on the therapeutic areas comprising oncology, hematology, rheumatology, auto-immune diseases, allergy, and dermatology. Its primary products are IXINITY, an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with hemophilia B; Rasuvo and Metoject, a formulation of methotrexate designed to treat rheumatoid arthritis and other auto-immune diseases; Rupall, a prescription allergy medication; and Gleolan, an optical imaging agent indicated in patients with glioma as an adjunct for the visualization of malignant tissue during surgery.